How GSK's Data Partnership May Impact Healthcare Policy in the Greater Bay Area The news that GlaxoSmithKline (GSK) has partnered with Hong Kong University to analyze data from the 88 million residents of the Greater Bay Area has sparked a mix of reactions in the healthcare community.
On one hand, the partnership promises significant benefits for public health policy and vaccine development.
On the other hand, it raises concerns about pharmaceutical companies exploiting vast amounts of personal medical information.